Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05UPB
|
|||
Former ID |
DNC000428
|
|||
Drug Name |
CI-972
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Rheumatoid arthritis [ICD-11: FA20] | Discontinued in Phase 1 | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C11H12ClN5OS
|
|||
Canonical SMILES |
C1=CSC=C1CC2=C(NC3=C2N=C(NC3=O)N)N.Cl
|
|||
InChI |
1S/C11H11N5OS.ClH/c12-9-6(3-5-1-2-18-4-5)7-8(14-9)10(17)16-11(13)15-7;/h1-2,4,14H,3,12H2,(H3,13,15,16,17);1H
|
|||
InChIKey |
SLNICZJKQXPOJA-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 115787-68-3
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
SuperDrug ATC ID |
P01BE05
|
|||
SuperDrug CAS ID |
cas=081496813
|
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002367) | |||
REF 2 | Inhibitors of human purine nucleoside phosphorylase. Synthesis of pyrrolo[3,2-d]pyrimidines, a new class of purine nucleoside phosphorylase inhibitors as potentially T-cell selective immunosuppressive agents. Description of 2,6-diamino-3,5-dihydro-7-(3-thienylmethyl)-4H-pyrrolo[3,2-d] pyrimidin-4-one. J Med Chem. 1992 May 1;35(9):1605-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.